Difference between revisions of "Minutes - Medication WG 2022-02-15"

From Health Level 7 Belgium Wiki
 
(3 intermediate revisions by the same user not shown)
Line 34: Line 34:
 
===== '''Agenda''' =====
 
===== '''Agenda''' =====
 
* presentation and discussion on drug databases
 
* presentation and discussion on drug databases
 
  
 
===== '''Minutes''' =====
 
===== '''Minutes''' =====
* An from Digile has worked on the SAM database and has plenty of drug data expertise
+
* An from Digile presents [https://drive.google.com/file/d/1PG0ckqOqglzQqbu5OHsTjgGwKfA-KKbI/view?usp=sharing their work on the SAM database and their drug data expertise]
 
::* BCFI, the green booklet used by pharmacists & doctors
 
::* BCFI, the green booklet used by pharmacists & doctors
 
::::* BCFI was structured in a Repertorium drug tables
 
::::* BCFI was structured in a Repertorium drug tables
Line 52: Line 51:
 
* How can we query with FHIR on SAMv2 ? There is a restful API but not on FHIR  
 
* How can we query with FHIR on SAMv2 ? There is a restful API but not on FHIR  
 
::* f.e. if doctor wants to query on substance
 
::* f.e. if doctor wants to query on substance
::* what are the logical models behind: see https://www.samportal.be/nl/sam/documentation PIM logical model
+
::* what are the logical models behind: see https://www.samportal.be/nl/sam/documentation, technical documentation section has the  PIM logical model
 
* what is a VMP group: it is a clinical concept for medicinal products having the same substance, strength, pharmaceutical form and route of administration - seen from the point of view of a clinician (doctor, pharmacist)
 
* what is a VMP group: it is a clinical concept for medicinal products having the same substance, strength, pharmaceutical form and route of administration - seen from the point of view of a clinician (doctor, pharmacist)
 
* VMP is a more regulatory concept
 
* VMP is a more regulatory concept
Line 68: Line 67:
 
'''Agenda items for next meeting'''
 
'''Agenda items for next meeting'''
 
* medication treatment line examples
 
* medication treatment line examples
* discuss document
+
* discuss document listing the concepts to use in the MS.
 +
 
 
'''Next meeting March 1 at 11AM'''
 
'''Next meeting March 1 at 11AM'''

Latest revision as of 09:50, 16 February 2022

Attendees
  • An Crepel, Digile
  • Annemieke Vergauwe
  • Bart Decuypere
  • Jan Lenie
  • Jean-Michel Polfliet
  • Jens Penny
  • José Costa Teixeira
  • Karlien Erauw
  • Kris Deceunynck
  • Pablo Christiaens
  • Thomas Van Langendonck
  • Tom Henkens
Excused/Not present
  • Anne Nerenhausen
  • Bruno Casneuf
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Hanne Vuegen
  • Jean-Louis Maggetto
  • Jeroen De Wilde
  • Katrien Thorré
  • Lars Vanreppelen
  • Marc Buckens
  • Nick Hermans
  • Nils Devos
  • Richard Francken
  • Thomas Van Langendonck
  • Tom De Backer
  • Walter Bollaert
  • Will van Norel
Agenda
  • presentation and discussion on drug databases
Minutes
  • BCFI, the green booklet used by pharmacists & doctors
  • BCFI was structured in a Repertorium drug tables
  • SAM is a consortium: APB, RIZIV, FOD VG, FAGG to put all drugs in one database
  • VMP, VMP-groups are concepts that were implemented through guidance from BCFI
  • the public SAM viewer was developed by Digile, visualisation in an intuitive manner that has the full SAMv2 content (2 updates a day - not realtime), search is intuitive by brand, substance, code (CTI-extended, CNK), has the business history
  • feedback option is available for the pharma and industry as there are still some data quality issues & inconsistencies with SAM
  • follow-up on raised issues is still difficult
  • CSV experts are available f.e. for overview of VOS-groups to improve easier access to these data that was not open to the public before
  • ISO IDMP gap analysis on SAM V2 has been done
  • ISO IDMP does not present a fixed vocabulary
  • objective is to map SAMv2 to ISO IDMP database, works quite well although there are no identifiers in the 2 systems
  • attributes can be useful for the mapping
  • How can we query with FHIR on SAMv2 ? There is a restful API but not on FHIR
  • what is a VMP group: it is a clinical concept for medicinal products having the same substance, strength, pharmaceutical form and route of administration - seen from the point of view of a clinician (doctor, pharmacist)
  • VMP is a more regulatory concept
  • our WG goal: how to represent medication in a medication scheme - which recommendation to represent the medication ? The current MS is focused on brand name ; VOS-group of substance seems better from a clinical point of view as it includes the route of administration
  • RIZIV wants a different view so both levels will have to be there (packages)
  • The VIDIS project would like to have first artefacts of our WG
  • medication treatment line are being worked on - we need some use cases/examples to make progress - will be ready for next meeting


Action items for next meeting

  • José to work on use cases and add medication view line in view and how it all works at operational level

Agenda items for next meeting

  • medication treatment line examples
  • discuss document listing the concepts to use in the MS.

Next meeting March 1 at 11AM